Skip to main content
Amoy Diagnostics Co.,Ltd. logo

Amoy Diagnostics Co.,Ltd. — Investor Relations & Filings

Ticker · 300685 ISIN · CNE1000034D3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,088 across all filing types
Latest filing 2026-05-20 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300685

About Amoy Diagnostics Co.,Ltd.

https://www.amoydx.com

Amoy Diagnostics Co., Ltd. specializes in the development and commercialization of molecular diagnostic products for precision oncology. The company provides a comprehensive portfolio of testing kits designed to identify genetic mutations and biomarkers essential for personalized cancer treatment. Its core technology platforms include the proprietary ADx-ARMS, Super-ARMS, and specialized Next-Generation Sequencing (NGS) solutions. AmoyDx focuses on companion diagnostics (CDx), collaborating extensively with global pharmaceutical companies to integrate diagnostic testing into clinical drug development and patient management. Key products cover a wide range of solid tumors, including lung, colorectal, and breast cancers, facilitating targeted therapy selection and monitoring. The company maintains rigorous quality standards, with numerous products receiving regulatory approvals for clinical use in multiple international markets.

Recent filings

Filing Released Lang Actions
关于公司获得医疗器械注册证的公告
Regulatory Filings Classification · 85% confidence The document is a routine corporate disclosure announcing that the company has obtained a medical device registration certificate from the National Medical Products Administration. It contains no financial statements, isn’t a shareholder meeting material, earnings release, or any of the other specific categories. This fits the general regulatory announcement / compliance category as a fallback.
2026-05-20 Chinese
关于公司获得医疗器械注册证的公告
Regulatory Filings Classification · 80% confidence The document is a public announcement by the company that it has obtained two medical device registration certificates from the National Medical Products Administration. It is a compliance/regulatory disclosure rather than a financial report, earnings release, management change, or other specific category. Therefore it falls under the generic Regulatory Filings (RNS) category.
2026-05-12 Chinese
2025年度权益分派实施的公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2025 annual dividend distribution plan by the company. It details the dividend amount per share, the total cash dividend, the record date, the ex-dividend date, and other related procedural information. It explicitly states that the dividend plan was approved at the 2025 annual shareholders meeting and provides specifics on the dividend payment method and tax treatment. The document does not contain financial statements or comprehensive financial performance data but focuses solely on the dividend distribution details. Therefore, it fits the category of a Notice of Dividend Amount (DIV) rather than an Annual Report or Earnings Release. The document length is relatively short (2223 characters), and it is a formal announcement of dividend distribution, not a full report or financial statement.
2026-05-08 Chinese
关于公司获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of medical device registration certificates issued by the National Medical Products Administration of China. It details the product names, registration classifications, certificate numbers, validity periods, and intended uses. The document includes a statement from the board ensuring the accuracy of the disclosure and discusses the potential impact and risks related to the new certifications. There is no financial data, no mention of financial results, no regulatory filings or certifications, no voting results, no management changes, no merger or acquisition activity, and no report publication. The document is a regulatory announcement about product registration and compliance, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories.
2026-05-08 Chinese
关于取得日本发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (441 characters) about the company receiving a Japanese invention patent certificate. It includes details about the patent but does not contain financial data, regulatory filings, or any report type such as annual or interim reports. It is not related to board changes, voting results, or capital changes. The document is an official announcement regarding intellectual property, which does not fit into any specific financial report category. Given the content and length, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other categories.
2026-05-08 Chinese
2025年年度股东会法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and compliance of the 2025 Annual General Meeting (AGM) of Xiamen Aide Biomedical Technology Co., Ltd. It details the procedures of convening and holding the AGM, the qualifications of attendees, the voting procedures, and the voting results. The document does not contain financial statements or detailed financial performance data, but rather focuses on the legal validation of the AGM process and its outcomes. The document length is 3745 characters, which is relatively short and consistent with a legal opinion letter rather than a full report. It is not an announcement of the AGM materials or voting results but a legal opinion on the AGM itself. Therefore, the document fits best into the category of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting, including legal opinions related to the AGM.
2026-05-07 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.